- Erythromycin, pimozide, quinidine
- QT prolongation and torsade de pointes. Contraindicated.
- Warfarin and other coumarins
- Raises prothrombin time, with bleeding reported. Monitor PT/INR and adjust warfarin.
- Sulfonylureas (glipizide, glyburide, tolbutamide)
- Raises their levels; hypoglycemia, including one death with glyburide. Monitor glucose and adjust the sulfonylurea.
- Phenytoin
- Raises phenytoin levels (AUC up 88% in one study). Monitor phenytoin levels.
- Statins cleared by CYP3A4 or CYP2C9 (atorvastatin, simvastatin, fluvastatin)
- Higher risk of myopathy and rhabdomyolysis. Watch symptoms and CK; stop the statin if CK rises markedly.
- Cyclosporine, tacrolimus, sirolimus
- Raises their levels; oral tacrolimus up to 5 times, with nephrotoxicity. Monitor levels and creatinine.
- Amiodarone and other QT-prolonging drugs
- Added QT prolongation, notably with 800 mg doses. Use caution.
- Midazolam, triazolam
- Much higher benzodiazepine levels and sedation. Consider lower doses.
- Rifampin
- Speeds fluconazole clearance. Consider a higher fluconazole dose.
- Carbamazepine, theophylline
- Raises their levels (carbamazepine about 30%). Monitor levels or effect.
- Fentanyl, methadone
- Raises opioid levels; one fatal fentanyl case was reported. Watch for respiratory depression.